312 related articles for article (PubMed ID: 25339395)
1. Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen testing.
Chakravorty S; Lee JS; Cho EJ; Roh SS; Smith LE; Lee J; Kim CT; Via LE; Cho SN; Barry CE; Alland D
J Clin Microbiol; 2015 Jan; 53(1):43-51. PubMed ID: 25339395
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.
Georghiou SB; Magana M; Garfein RS; Catanzaro DG; Catanzaro A; Rodwell TC
PLoS One; 2012; 7(3):e33275. PubMed ID: 22479378
[TBL] [Abstract][Full Text] [Related]
3. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China.
Du Q; Dai G; Long Q; Yu X; Dong L; Huang H; Xie J
Diagn Microbiol Infect Dis; 2013 Oct; 77(2):138-42. PubMed ID: 23948547
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
[TBL] [Abstract][Full Text] [Related]
6. Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.
Brossier F; Guindo D; Pham A; Reibel F; Sougakoff W; Veziris N; Aubry A
J Clin Microbiol; 2016 Jun; 54(6):1573-1580. PubMed ID: 27053671
[TBL] [Abstract][Full Text] [Related]
7. Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China.
Zhang Z; Liu M; Wang Y; Pang Y; Kam KM; Zhao Y
Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):1959-66. PubMed ID: 24906439
[TBL] [Abstract][Full Text] [Related]
8. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of mutations associated with resistance to second line drugs in Mycobacterium tuberculosis patients from Casablanca, Morocco.
Momen G; Aainouss A; Lamaammal A; Chettioui F; Blaghen M; Messoudi M; Belghmi K; Mouslim J; El Mzibri M; El Messaoudi MD; Khyatti M; Chaoui I
Rev Inst Med Trop Sao Paulo; 2021; 63():e19. PubMed ID: 33787739
[TBL] [Abstract][Full Text] [Related]
10. Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use.
Chakravorty S; Roh SS; Glass J; Smith LE; Simmons AM; Lund K; Lokhov S; Liu X; Xu P; Zhang G; Via LE; Shen Q; Ruan X; Yuan X; Zhu HZ; Viazovkina E; Shenai S; Rowneki M; Lee JS; Barry CE; Gao Q; Persing D; Kwiatkawoski R; Jones M; Gall A; Alland D
J Clin Microbiol; 2017 Jan; 55(1):183-198. PubMed ID: 27807153
[TBL] [Abstract][Full Text] [Related]
11. Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing.
Ssengooba W; Nakayita G; Namaganda CC; Joloba ML
PLoS One; 2018; 13(6):e0199638. PubMed ID: 29953491
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries.
Ajbani K; Lin SY; Rodrigues C; Nguyen D; Arroyo F; Kaping J; Jackson L; Garfein RS; Catanzaro D; Eisenach K; Victor TC; Crudu V; Gler MT; Ismail N; Desmond E; Catanzaro A; Rodwell TC
Antimicrob Agents Chemother; 2015 Jan; 59(1):414-20. PubMed ID: 25367911
[TBL] [Abstract][Full Text] [Related]
13. Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association Study.
Conkle-Gutierrez D; Kim C; Ramirez-Busby SM; Modlin SJ; Mansjö M; Werngren J; Rigouts L; Hoffner SE; Valafar F
Antimicrob Agents Chemother; 2022 Jun; 66(6):e0207521. PubMed ID: 35532237
[TBL] [Abstract][Full Text] [Related]
14. Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis.
Habibnia S; Karami-Zarandi M; Zaker S; Ghalavand Z; Doustdar F; Eslami G; Kazemian H
Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649505
[TBL] [Abstract][Full Text] [Related]
15. Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.
Safari M; Moghim S; Salehi M; Jafari R; Nasr Esfahani B
Infect Genet Evol; 2020 Nov; 85():104468. PubMed ID: 32711076
[TBL] [Abstract][Full Text] [Related]
16. The role of eis mutations in the development of kanamycin resistance in Mycobacterium tuberculosis isolates from the Moscow region.
Gikalo MB; Nosova EY; Krylova LY; Moroz AM
J Antimicrob Chemother; 2012 Sep; 67(9):2107-9. PubMed ID: 22593564
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis.
Sirgel FA; Tait M; Warren RM; Streicher EM; Böttger EC; van Helden PD; Gey van Pittius NC; Coetzee G; Hoosain EY; Chabula-Nxiweni M; Hayes C; Victor TC; Trollip A
Microb Drug Resist; 2012 Apr; 18(2):193-7. PubMed ID: 21732736
[TBL] [Abstract][Full Text] [Related]
18. Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin.
Sugawara I; Zhang J; Li C
Indian J Exp Biol; 2009 Jun; 47(6):520-2. PubMed ID: 19634718
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and molecular characterization of amikacin resistance among Mycobacterium tuberculosis clinical isolates from southern China.
Islam MM; Tan Y; Hameed HMA; Liu Y; Chhotaray C; Cai X; Liu Z; Lu Z; Wang S; Cai X; Su B; Li X; Tan S; Liu J; Zhang T
J Glob Antimicrob Resist; 2020 Sep; 22():290-295. PubMed ID: 32142951
[TBL] [Abstract][Full Text] [Related]
20. [Using of the Sensititre MycoTB Plate Method for the Detection of Anti-tuberculous Drug Susceptibility of Rifampin Resistant Mycobacterium tuberculosis Complex Isolates].
Ceyhan İ; Vezir S
Mikrobiyol Bul; 2020 Apr; 54(2):211-222. PubMed ID: 32723277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
